European Archives - Page 135 of 1345 - European Medical Journal

Novel Oral Polio Vaccines Show Strong Safety and Immune Response

A Phase 1 USA trial finds novel oral polio vaccines nOPV1 and nOPV3 to be safe, highly immunogenic, and comparable to Sabin-strain vaccines, paving the way for Phase 2 studies.

Real-World Data Reveals Safety Patterns of Biologics in Paediatric IBD

A large safety analysis of infliximab and adalimumab in pediatric inflammatory bowel disease highlights the need for continued postmarketing monitoring, with new concerns emerging for long-term infliximab use.

GLP-1 Receptor Agonists Show Promise in Hidradenitis Suppurativa

By Month 6 (M6), 50–60% achieved at least a one-point improvement across validated HS severity measures.

EMJ Dermatology 13 [Supplement 3] 2025

In this interview, two dermatology experts from Germany share their treatment experiences of using lebrikizumab to treat patients with…

The Evolving Atopic Dermatitis Treatment Landscape

Experts provide real-life insights and case examples of managing moderate-to-severe atopic dermatitis, sharing their treatment experience with lebrikizumab.

NICE launches landmark guidance in type 2 diabetes

NICE unveils new type 2 diabetes guidance, promoting earlier access to advanced therapies such as SGLT-2 inhibitors and more.

Long COVID: Cardiovascular Patterns Revealed with Smartwatch Biometrics

Wearables reveal unique activity and heart rate patterns in long COVID, showing promise as clinical biomarkers.

Pyridostigmine Boosts Recovery in Underactive Bladder Post-TURP

Taken together, the findings suggest that targeted augmentation of cholinergic signalling may help bridge the gap between anatomical de-obstruction and functional recovery in BOO-mediated UAB.

Renal Dysfunction Persists Despite Pulmonary Hypertension Treatment

A large pooled analysis shows that kidney problems are common in PAH and CTEPH, worsen survival, and see only minor improvement with current pulmonary hypertension therapies.

Headshots of Julia Strandberg, Yacin Marzouki and Catarina Sobral.

Pharma marketing: What’s working for HCPs in 2025

Pharma marketing experts reveal what’s working to engage time-pressed HCPs in 2025, with practical insights and metrics for improving impact.